MedTrace Logo

Mitral Valve in Hypertrophic Cardiomyopathy

NCT03877731 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-01-13

No results posted yet for this study

Summary

The purpose of the study is to assess the role of mitral valve apparatus in the development of outflow tract obstruction in patients with hypertrophic cardiomyopathy and to identify the best surgical treatment modality to relieve outflow tract obstruction in such patients

Conditions

  • Hypertrophic Obstructive Cardiomyopathy

Interventions

PROCEDURE

isolated septal myectomy

PROCEDURE

septal myectomy + edge-to-edge mitral valve repair

PROCEDURE

septal myectomy + posterior leaflet sliding plasty

PROCEDURE

septal myectomy + secondary chordae transection

Sponsors & Collaborators

  • Tomsk National Research Medical Center of the Russian Academy of Sciences

    lead OTHER

Principal Investigators

  • Elena Pavlyukova, MD, PhD · Cardiology Research Institute, Tomsk NRMC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-12-01
Primary Completion
2019-05-30
Completion
2019-09-01

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03877731 on ClinicalTrials.gov